Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
58011 Results Found
LTCH PPS FY 2017 Proposed Rule Call Slides
Slides from the May 19, 2016, AHA member call on LTCH PPS FY 2017 Proposed Rule.
AHA Affordability Data Book
@media only screen and (min-width : 324px) and (max-width : 767px) {.tablet, .desktop {display: none;}}
@media only screen and (min-width : 768px) and (max-width : 1028px) {.mo
October 27, 2016 Hosptital/FQHC Relations
By collaborating, hospital providers have expanded access, improved efficiency, enhanced the health of the population and maximized resource utilization by avoiding unnecessary duplication of services while directing patients toward the appropriate site of service.
AHA Presentation on Hospital/FQHC Relations
By collaborating, hospital providers have expanded access, improved efficiency, enhanced the health of the population and maximized resource utilization by avoiding unnecessary duplication of services while directing patients toward the appropriate site of service.
October 4, 2016 Hospital/FQHC ACO Partnership of Maine
Twelve health care organizations across the state have partnered to form the Community Care Partnership of Maine - an Accountable Care Organization (CCPM ACO).
October 4, 2016 Hospital/FQHC ACO Partnership of Maine - Case Study
Twelve health care organizations across the state have partnered to form the Community Care Partnership of Maine - an Accountable Care Organization (CCPM ACO). Case Study
TrendWatch Report: The Role of Post-Acute Care in New Care Delivery Models
Post-acute care providers play an essential role in ensuring that patients receive the care they need to heal and have a smooth transition back to a community-based setting, typically after a disch
Thomas C. Dolan, Ph.D. - In First Person: An Oral History
Edited by Kim M. Garber and Jessica D. Squazzo
AHA Statement to the Senate Help Committee on 340B
AHA Statement before the Senate Committee on Health, Education, Labor and Pensions Re: Perspectives on the 340B Drug Pricing Program